'

Products

Cerviron zoom

Hover

Cerviron
Full Screen

Cerviron®

79.00 AED

Cerviron vaginal ovules contain 7 active components that confer their beneficial therapeutic properties in multiple disorders of the female genital tract including acute and chronic vulvovaginitis; cervical erosions of various etiologies, simple or infected; leucorrhea; vulvar itching; pre and postoperative treatment in gynecological surgery.

Description

Cerviron vaginal ovules contain 7 active components that confer their beneficial therapeutic properties in multiple disorders of the female genital tract.

These properties are due to the cumulative or antagonistic effects of the components, and the low concentrations in which they are found, which avoids any unwanted local effects. These also stimulate the immune system, restoring the initial colpoecosystem (the vaginal ecosystem, which integrates into a dynamic functional unit a biotic communion, biocenosis, consisting of all the interacting microorganisms in the vagina), without affecting the Doderlein Bacilli, from the vagina, which creates conditions conducive to their development.

All of these active components are incorporated in an inert base of suppositories; semi-synthetic glycerides; which ensure a homogeneous dispersion. Due to this composition, Cerviron
diminishes or removes the inflammatory phenomena in the vagina and cervix, has antiseptic effects on the pathogenic intravaginal flora, but also favors the restoration of the normal microflora. It also diminishes or cures the erosions of the cervix, completely or partially restores the mucus, and decreases pain, burning sensations and itching in the female genital tract that are accompanied by pathological hypersecretion and local and general discomfort.

Qualitative and quantitative composition

An ovule contains bismuth subgallate – 100 mg, hydrolyzed collagen – 15,0 mg, thyme extract (Thymus vulgaris) – 10 mg, Hydrastis Canadensis extract – 10
mg, calendula glycolic extract (Calendula ocinalis) – 10 mg, Turmeric extract (Curcuma longa) – 10 mg,
hexylresorcinol – 2,0 mg.

Dosage and administration

The recommended dose is 1 Cerviron ovule vaginally administered, in the evening, preferably following the vaginal irrigation. The treatment starts on the rst day after ending the menstruation and is administered for 10 – 15 days a month. It may be repeated for several months, until recovery or for consolidating and maintaining the favourable eects attained.

Nature and content of the package

2 thermo-welded foils made of PVC/PE, of 5 ovules each.

Manufacturer

Perfect Care Distribution SRL,
Str. Nicolae Pascu, nr. 4, Bl. R2, Sc. A, Sector 3,
Bucharest, Romania

Downloads

Reviews

There are no reviews yet.

Be the first to review “Cerviron®”

Your email address will not be published. Required fields are marked *

TOP
0
    0
    Your Cart
    Your cart is empty